This is a preview of subscription content, log in via an institution to check access.
References
Rosenberg, S.A., Yang, J.C. & Restifo, N.P. Nat. Med. 10, 909–915 (2004).
Miller, A.B., Hoogstraten, B., Staquet, M & Winkler, A. Cancer 47, 207–214 (1981).
Therasse, P. et al. J. Natl. Cancer Inst. 92, 205–216 (2000).
Dudley, M.E. et al. Science 298, 850–854 (2002).
Overwijk, W.W. et al. J. Exp. Med. 198, 569–580 (2003).
Klebanoff, C.A. et al. Proc. Natl. Acad. Sci. USA 101, 1969–1974 (2004).
Rosenberg, S.A. & Dudley, M.E. Proc. Natl. Acad. Sci. USA 101, 14639–14645 (2004).
Timmerman, J.M. et al. Blood 99, 1517–1526 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosenberg, S., Yang, J. & Restifo, N. Reply to "Cancer vaccines: pessimism in check". Nat Med 10, 1279–1280 (2004). https://doi.org/10.1038/nm1204-1279b
Issue Date:
DOI: https://doi.org/10.1038/nm1204-1279b
- Springer Nature America, Inc.
This article is cited by
-
Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy
Clinical & Experimental Metastasis (2014)
-
VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model
Breast Cancer Research and Treatment (2007)
-
A balanced review of the status T cell-based therapy against cancer
Journal of Translational Medicine (2005)
-
Recent developments in therapeutic cancer vaccines
Nature Clinical Practice Oncology (2005)